These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 336499)

  • 1. [Cytopherometry in neurologic diseases (author's transl)].
    Meyer-Rienecker HJ; Jenssen HL; Köhler H; Werner H
    Fortschr Neurol Psychiatr Grenzgeb; 1977 Nov; 45(11):615-29. PubMed ID: 336499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The macrophage electrophoretic mobility LAD test--a diagnostic method for multiple sclerosis (author's transl)].
    Meyer-Rienecker H; Jenessen HL; Köhler H; Günther JK
    J Neurol; 1976 Feb; 211(3):229-40. PubMed ID: 55489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cellular immunity in neurological diseases. Results with myelinbasic protein (author's transl)].
    Meyer-Rienecker H; Jenssen HL; Köhler H; Lehmitz R; Schmieter K
    Nervenarzt; 1979 Jan; 50(1):10-5. PubMed ID: 85265
    [No Abstract]   [Full Text] [Related]  

  • 4. [Demonstration of a factor in cerebrospinal fluid with inhibitory activity for electrophoretic cell mobility in multiple sclerosis (author's transl)].
    Jenssen HL; Meyer-Rienecker HJ; Werner H
    J Neurol; 1976 Nov; 214(1):45-59. PubMed ID: 62827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of the macrophage-electrophoretic-mobility test in the diagnosis of tumours of the central nervous system (author's transl)].
    Meyer-Rienecker H; Jenssen HL; Köhler H; Günther JK
    Dtsch Med Wochenschr; 1975 Mar; 100(11):538-43. PubMed ID: 163724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heterogenous immune reactivity in brain tumors: results of cellular immunity in relation to brain tissue antigens].
    Meyer-Rienecker HJ; Jenssen HL; Mix E
    Fortschr Neurol Psychiatr; 1985 Oct; 53(10):363-9. PubMed ID: 2415433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
    Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
    Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenetic aspects of neuroimmunologic diseases].
    Meyer-Rienecker HJ; Hitzschke B; Wegener S; Jenssen HL
    Z Arztl Fortbild (Jena); 1983; 77(1):7-12. PubMed ID: 6845759
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
    Metzner G; Jäger L
    Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic problem in multiple sclerosis (M.S.): two specific laboratory tests.
    Field EJ
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):552-6. PubMed ID: 75734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
    Lee Y; Bigner DD
    Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte sensitization detected by the macrophage electrophoretic mobility assay in patients with renal cell carcinoma: Theophylline increases the sensitivity of the assay.
    Malkovský M; Bubeník J; Malkovská V; Indrová M; Suhajová E; Jakoubková J; Jíra M
    Arch Geschwulstforsch; 1981; 51(4):364-70. PubMed ID: 7032451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Developmental trends in neuroimmunology. 1: Principles, immuno-components, immunogenetics, contributions of virology].
    Meyer-Rienecker HJ
    Nervenarzt; 1984 Dec; 55(12):617-24. PubMed ID: 6441125
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroimmunology I: Immunoregulation in neurological disease.
    Weiner HL; Hauser SL
    Ann Neurol; 1982 May; 11(5):437-49. PubMed ID: 6179458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas.
    Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C
    Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells.
    Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M
    Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of the macrophage electrophoretic mobility test (M.E.M.).
    Shenton BR
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):557-64. PubMed ID: 629849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recording of cell-mediated immunity in patients with gliomatous brain tumors].
    Lambrecht R; Willenberg E; Plate M
    Z Exp Chir Transplant Kunstliche Organe; 1986; 19(3):167-71. PubMed ID: 3751205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.